The anticipated annualized base pay range for this full-time position is $202,000-$246,000. Ardelyx utilizes industry data to ensure that our compensation is competitive and aligned with our industry peers. Actual base pay will be determined based on a variety of factors, including years of relevant experience, training, qualifications, and internal equity. The compensation package may also include an annual bonus target and equity awards, subject to eligibility and other requirements. Ardelyx also offers a robust benefits package to employees, including a 401(k) plan with generous employer match, 12 weeks of paid parental leave, up to 12 weeks of living organ and bone marrow leave, equity incentive plans, health plans (medical, prescription drug, dental, and vision), life insurance and disability, flexible time off, annual Winter Holiday shut down, and at least 11 paid holidays.

Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada.

Position Summary

Reporting to the SVP, Legal and working closely with business leadership, the Securities and Corporate Governance Counsel will play a lead role in all public company matters and ongoing compliance, corporate governance, and corporate financing transactions. The successful candidate will be a pragmatic, creative and business-focused attorney with significant experience across multiple disciplines including, securities, corporate governance, and related counseling. They will collaborate with internal, cross-functional team members as well as interface with outside counsel and a broad range of vendors.

Responsibilities

Manage day-to-day securities work in conjunction with outside counsel and internal stakeholders with direct oversight of public company SEC filings and advise the business with respect to securities and public disclosure requirements
Review and comment on corporate communications and related public company disclosures as needed to ensure consistency with securities laws
Monitor and advise on the potential impact of new and proposed securities laws and regulations; Nasdaq rule changes; ISS and other proxy advisory firms’ as well as institutional investors’ voting policy changes and developments, trends and evolving best practices in corporate governance and ESG
Support the SVP, Legal, as needed, on corporate governance, ethics and compliance matters, including Board agendas, corporate policies, Board committee charters, minutes, resolutions/consents and related activities
Advise on equity, executive compensation, and stock administration matters working in conjunction with the Finance and HR teams
Advise senior management on internal securities matters, including Reg FD, trading windows, 10b5-1 plans and Section 16 compliance
Collaborate with other legal team members to train and advise all employees on insider trading matters, company code of conduct and other corporate governance policies
Collaborate with other legal team members to ensure Ardelyx’s compliance with FDA, HHS/OIG, FCPA, and GDPR requirements and other applicable laws, rules and regulations and stay abreast of relevant industry-wide developments
Maintain and update the company diligence data room, and respond to diligence requests from third parties

Qualifications

J.D. with strong academic credentials from a nationally recognized law school
Active member of the Massachusetts State Bar, California State Bar, or licensed to practice in state of residence with 4+ years of experience practicing at a major law firm or equivalent experience
Strong preference for at least 2+ years in-house with a pharmaceutical or biotech company
Significant knowledge of US securities law and experience in advising public companies of their reporting requirements
Significant responsibility for 1933 Act equity and debt securities offerings and 1934 Act matters, including proxy statements, periodic reporting on Forms 10-K, 10-Q and 8-K
Strong understanding of Nasdaq regulations
Direct experience advising public companies on corporate governance matters
Direct experience working with corporate leadership
A preferred candidate is one who wants to develop professionally by learning about new subject matters and thinking strategically
Meticulous attention to detail required
Team-focused and cross-functional, collaborative work style are critical
Exceptional critical thinking and problem-solving skills
Ability to work in a fast-paced, high-volume environment and meet deadlines
Excellent verbal and written communication skills, including strong listening skills
Self-motivated, enthusiastic and intellectually curious
Strong sense of accountability and ownership, highly collaborative with the ability to independently and effectively manage a substantial workload in a fast-paced, rapidly evolving environment
Ability to travel periodically as needed

Create a Job Match for Similar Jobs

About Ardelyx

Here at Ardelyx®, we are dedicated to improving the lives of patients by discovering, developing, and commercializing first-in-class medicines that advance patient care. Using our discovery model, Ardelyx scientists identified new biological mechanisms that enabled us to develop medicines designed to address significant unmet medical needs with the goal of improving outcomes for patients.Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop, and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada.

Connections working at Ardelyx

https://jobs.isaca.org/jobs/21746099/senior-manager-securities-and-corporate-governance-counsel

Loading...

Summary:

Captcha / Bot check:

Error